PLAT and COVID-19: Considering the recent approval of clinical trials based on the inhalation of fibrinolytic drugs such as t-PA [42], the present study opens up the opportunity for adjunctive therapy regimes based on the repurposing of PLG-OMP as inhalable medicine for the treatment of ARDS in COVID-19 patients.